Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FVIII Deficiency”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 31
Not applicableLooking for participantsNCT02979119
What this trial is testing

The European Paediatric Network for Haemophilia Management ( PedNet Registry)

Who this might be right for
Factor VIII DeficiencyFactor IX Deficiency
PedNet Haemophilia Research Foundation 4,000
Not applicableStudy completedNCT00341705
What this trial is testing

The Second Multicenter Hemophilia Cohort Study

Who this might be right for
Liver DecompensationHepatocellular CarcinomaNon-Hodgkin Lymphoma
National Cancer Institute (NCI) 2,565
Not applicableStudy completedNCT03876301
What this trial is testing

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

Who this might be right for
Blood Coagulation DisorderBlood Coagulation Disorders, InheritedCoagulation Protein Disorders+6 more
Spark Therapeutics, Inc. 25
Large-scale testing (Phase 3)Study completedNCT04161495
What this trial is testing

Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A

Who this might be right for
Factor VIII Deficiency
Bioverativ, a Sanofi company 159
Not applicableStudy completedNCT03006965
What this trial is testing

Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®

Who this might be right for
Hemophilia AHemophiliaFactor VIII Deficiency
Spanish Society of Thrombosis and Haemostasis 50
Post-approval studies (Phase 4)Looking for participantsNCT04567511
What this trial is testing

Hemlibra in Mild Hemophilia A

Who this might be right for
Factor VIII Deficiency, Congenital
Indiana Hemophilia &Thrombosis Center, Inc. 20
Not applicableLooking for participantsNCT06550882
What this trial is testing

OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Who this might be right for
Acquired Hemophilia A
Takeda 9
Large-scale testing (Phase 3)Ended earlyNCT00306670
What this trial is testing

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Who this might be right for
Hemophilia A
Georgetown University 2
Testing effectiveness (Phase 2)Study completedNCT04188639
What this trial is testing

Emicizumab in Acquired Hemophilia A

Who this might be right for
Hemophilia A, Acquired
GWT-TUD GmbH 47
Large-scale testing (Phase 3)Study completedNCT00189982
What this trial is testing

Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345197
What this trial is testing

Emicizumab in Patients With Acquired Hemophilia A

Who this might be right for
Acquired Hemophilia A
University of Washington 51
Not applicableStudy completedNCT02093741
What this trial is testing

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Who this might be right for
Hemophilia ACongenital Factor VIII (FVIII) Deficiency
Baxalta now part of Shire 65
Not applicableStudy completedNCT03199794
What this trial is testing

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Who this might be right for
Acquired Hemophilia A
Baxalta now part of Shire 50
Post-approval studies (Phase 4)Study completedNCT03384277
What this trial is testing

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

Who this might be right for
Acquired Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China 66
Testing effectiveness (Phase 2)UnknownNCT03700229
What this trial is testing

Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A

Who this might be right for
Acquired Hemophilia A
Peking Union Medical College Hospital 22
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Jiangsu Gensciences lnc. 27
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Large-scale testing (Phase 3)Study completedNCT00157040
What this trial is testing

Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 50
Post-approval studies (Phase 4)UnknownNCT02314325
What this trial is testing

Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens

Who this might be right for
Severe Haemophilia A
St. James's Hospital, Ireland 20
Load More Results